MyFinsight
Home
Blog
About
Contact
Download
Download image
Net proceeds from
issuances of common stock
$13,356,857
Net cash provided by
financing activities
$13,356,857
Net increase in cash
and cash...
$10,218,400
Canceled cashflow
$3,138,457
Accounts payable
$911,959
Research and development
supplies
-$299,020
Other current
liabilities
$266,904
Share-based compensation
$73,432
Net cash used in
operating activities
-$3,138,457
Canceled cashflow
$1,551,315
Net loss
-$4,461,895
Prepaid expenses and
other
$227,877
Back
Back
Cash Flow
source: myfinsight.com
Genprex, Inc. (GNPX)
Genprex, Inc. (GNPX)